Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
- Author
- GRIFFITHS, Christopher E. M1 ; STROBER, Bruce E2 ; DOOLEY, Lisa T6 ; GOLDSTEIN, Neil H7 ; MENTER, Alan8 ; VAN DE KERKHOF, Peter3 ; HO, Vincent4 ; FIDELUS-GORT, Roseanne5 ; YEILDING, Newman6 ; GUZZO, Cynthia6 ; YICHUAN XIA6 ; BEI ZHOU6 ; SHU LI6
[1] University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom
[2] New York University Medical Center, New York, United States
[3] University Hospital Nijmegen, Nijmegen, Netherlands
[4] University of British Columbia, Vancouver, BC, Canada
[5] Incyte Corporation, Wilmington, DE, United States
[6] Centocor Research and Development, Malvern, PA, United States
[7] Precision Research, Malvern, PA, United States
[8] Psoriasis Research Unit, Baylor University Medical Center, Dallas, United States
ACCEPT Study Group - Source
The New England journal of medicine. 2010, Vol 362, Num 2, pp 118-128, 11 p ; ref : 28 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antirhumatismal Etanercept Etude comparative Grave Immunomodulateur Médecine Psoriasis Forme grave Antagoniste Anti-TNF-alpha Anticytokine Cytokine Facteur nécrose tumorale α Pathologie de la peau Protéine fusion
- Keyword (en)
- Antirheumatic agent Etanercept Comparative study Severe Immunomodulator Medicine Psoriasis Antagonist Anti-Tumor Necrosis Factor-alpha Anticytokine Cytokine Tumor necrosis factor α Skin disease Fusion protein
- Keyword (es)
- Antireumático Etanercept Estudio comparativo Grave Inmunomodulador Medicina Psoriasis Antagonista Anti-TNF alfa Anticitoquina Citoquina Factor necrosis tumoral α Piel patología Proteína fusionada
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B08 Dermatology / 002B08D Psoriasis. Parapsoriasis. Lichen
- Discipline
- Dermatology Generalities in medical sciences
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 22336921
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa0810652 
https://dx.doi.org/10.1056/NEJMoa0810652
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0810652\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"362\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"118\";s:8:\"\u0000*\u0000epage\";s:3:\"128\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GRIFFITHS\";s:10:\"\u0000*\u0000aufirst\";s:16:\"Christopher E. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"STROBER, Bruce E\";i:1;s:14:\"DOOLEY, Lisa T\";i:2;s:17:\"GOLDSTEIN, Neil H\";i:3;s:12:\"MENTER, Alan\";i:4;s:21:\"VAN DE KERKHOF, Peter\";i:5;s:11:\"HO, Vincent\";i:6;s:22:\"FIDELUS-GORT, Roseanne\";i:7;s:16:\"YEILDING, Newman\";i:8;s:14:\"GUZZO, Cynthia\";i:9;s:11:\"YICHUAN XIA\";i:10;s:8:\"BEI ZHOU\";i:11;s:6:\"SHU LI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0810652\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"362\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"118\";s:8:\"\u0000*\u0000epage\";s:3:\"128\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GRIFFITHS\";s:10:\"\u0000*\u0000aufirst\";s:16:\"Christopher E. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"STROBER, Bruce E\";i:1;s:14:\"DOOLEY, Lisa T\";i:2;s:17:\"GOLDSTEIN, Neil H\";i:3;s:12:\"MENTER, Alan\";i:4;s:21:\"VAN DE KERKHOF, Peter\";i:5;s:11:\"HO, Vincent\";i:6;s:22:\"FIDELUS-GORT, Roseanne\";i:7;s:16:\"YEILDING, Newman\";i:8;s:14:\"GUZZO, Cynthia\";i:9;s:11:\"YICHUAN XIA\";i:10;s:8:\"BEI ZHOU\";i:11;s:6:\"SHU LI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0810652\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0810652\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"362\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"118\";s:8:\"\u0000*\u0000epage\";s:3:\"128\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GRIFFITHS\";s:10:\"\u0000*\u0000aufirst\";s:16:\"Christopher E. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"STROBER, Bruce E\";i:1;s:14:\"DOOLEY, Lisa T\";i:2;s:17:\"GOLDSTEIN, Neil H\";i:3;s:12:\"MENTER, Alan\";i:4;s:21:\"VAN DE KERKHOF, Peter\";i:5;s:11:\"HO, Vincent\";i:6;s:22:\"FIDELUS-GORT, Roseanne\";i:7;s:16:\"YEILDING, Newman\";i:8;s:14:\"GUZZO, Cynthia\";i:9;s:11:\"YICHUAN XIA\";i:10;s:8:\"BEI ZHOU\";i:11;s:6:\"SHU LI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0810652\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"362\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"118\";s:8:\"\u0000*\u0000epage\";s:3:\"128\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GRIFFITHS\";s:10:\"\u0000*\u0000aufirst\";s:16:\"Christopher E. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"STROBER, Bruce E\";i:1;s:14:\"DOOLEY, Lisa T\";i:2;s:17:\"GOLDSTEIN, Neil H\";i:3;s:12:\"MENTER, Alan\";i:4;s:21:\"VAN DE KERKHOF, Peter\";i:5;s:11:\"HO, Vincent\";i:6;s:22:\"FIDELUS-GORT, Roseanne\";i:7;s:16:\"YEILDING, Newman\";i:8;s:14:\"GUZZO, Cynthia\";i:9;s:11:\"YICHUAN XIA\";i:10;s:8:\"BEI ZHOU\";i:11;s:6:\"SHU LI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0810652\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"362\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"118\";s:8:\"\u0000*\u0000epage\";s:3:\"128\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"GRIFFITHS\";s:10:\"\u0000*\u0000aufirst\";s:16:\"Christopher E. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:16:\"STROBER, Bruce E\";i:1;s:14:\"DOOLEY, Lisa T\";i:2;s:17:\"GOLDSTEIN, Neil H\";i:3;s:12:\"MENTER, Alan\";i:4;s:21:\"VAN DE KERKHOF, Peter\";i:5;s:11:\"HO, Vincent\";i:6;s:22:\"FIDELUS-GORT, Roseanne\";i:7;s:16:\"YEILDING, Newman\";i:8;s:14:\"GUZZO, Cynthia\";i:9;s:11:\"YICHUAN XIA\";i:10;s:8:\"BEI ZHOU\";i:11;s:6:\"SHU LI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
